Supplier's Corner

Sabinsa Publishes Book On Tetrahydrocurcuminoids

...

Related CONTENT

11.02.12

Sabinsa, East Windsor, NJ, along with its scientific team has published the book Tetrahydrocurcuminoids, Curcumin C³ Reduct - The Cascading Antioxidant. The book discusses many aspects of tetrahydrocurcuminoids including its chemistry, pharmacology, preclinical, clinical and safety profile. In addition, it analyzes them as dietary supplements and discusses its use in cosmeceuticals and nutricosmetics. This is the latest in a series of books written about the science behind Sabinsa’s innovative ingredients. The books will be sent to Sabinsa’s Curcumin C3 Complex customers and to researchers who have studied curcumin.
For further information: www.sabinsa.com

Related Searches

Related Knowledge Center

Suggested For You

Sabinsa to Showcase Ingredients at Vitafoods Europe

Sabinsa to Showcase Ingredients at Vitafoods Europe

Sabinsa Gains Novel Food Approval for Curcumin C3 Reduct from EFSA

Sabinsa Gains Novel Food Approval for Curcumin C3 Reduct from EFSA

Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

Balancing Mood & Sleep in a Turbulent World

Balancing Mood & Sleep in a Turbulent World

Court Orders Olive Lifesciences to Pay Sabinsa $2.2 Million

Court Orders Olive Lifesciences to Pay Sabinsa $2.2 Million

Building Trust & Adding Value with Branded Ingredients

Building Trust & Adding Value with Branded Ingredients

Sabinsa Granted U.S. Patent on Lactospore for IBS

Sabinsa Granted U.S. Patent on Lactospore for IBS

Go for the Gold

Go for the Gold

Sabinsa to Highlight Recent Studies, New Canadian Health Claims

Sabinsa to Highlight Recent Studies, New Canadian Health Claims

Sabinsa’s Utah Facility Gains Foreign Site Registration Number From Canada

Sabinsa’s Utah Facility Gains Foreign Site Registration Number From Canada

Sabinsa’s LactoSpore Receives Health Canada Approval

Sabinsa’s LactoSpore Receives Health Canada Approval

Research from All American Pharmaceutical Published

Research from All American Pharmaceutical Published

ABC Publishes 100th Issue of HerbalGram

ABC Publishes 100th Issue of HerbalGram

IADSA Focuses on Stability Testing and Safety

IADSA Focuses on Stability Testing and Safety

Unigen Products Analyzed in Three Clinical Studies

Unigen Products Analyzed in Three Clinical Studies

Related Content

Sabinsa to Showcase Ingredients at Vitafoods Europe

The company will also present a scientific mini-seminar for its customers.
05.03.22
Breaking News | Herbs & Botanicals | Regulations | Regulatory News | Supplier News

Sabinsa Gains Novel Food Approval for Curcumin C3 Reduct from EFSA

The regulatory status paves the way for sale in the E.U.
02.17.22
Breaking News | Dietary Supplements | Herbs & Botanicals | Inflammation | Natural/Organic | Oral Health | Research | Supplier News

Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract

A preliminary study on Canker sores suggests that anti-inflammatory curcumin metabolites reduce inflammation at the source.
Mike Montemarano, Associate Editor 01.25.21
Consumer Trends | Dairy-Based Ingredients | Healthcare Trends | Herbs & Botanicals | Mood Health & Sleep

Balancing Mood & Sleep in a Turbulent World

Holistic health practices may help consumers reduce anxiety and improve sleep habits.
By Sean Moloughney, Editor 05.01.17
Breaking News | Certifications, Approvals & Patents | Regulations | Supplier News

Court Orders Olive Lifesciences to Pay Sabinsa $2.2 Million

U.S. District Court determined Olive ‘acted willfully in infringing’ on Curcumin C3 patent.
04.11.17